In honor of World Blindness Awareness Month, "GMA" is spotlighting a breakthrough gene therapy that's helping some blind ...
In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...
In the first part of this interview, Romanski tells PharmTech Group that while the field of oral dosage forms has not grown ...
Medication has long been the cornerstone of treatment for people with epilepsy, but it doesn’t stop seizures for everyone and ...
Cathy Tie, who launched her first biotech in SF's IndieBio, now leads Manhattan Genomics in controversial push to edit human ...
King Faisal Specialist Hospital & Research Centre (KFSHRC) has begun in-house manufacturing and clinical use of CAR-T cell ...
In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...
Live Science on MSNOpinion
One molecule could usher revolutionary medicines for cancer, diabetes and genetic disease — but the US is turning its back on it
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
Health Secretary Robert F. Kennedy Jr. called the treatment 'a powerful glimpse into the future of personalized medicine' ...
A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators reveals how melanoma, the deadliest form of skin ...
A GROUNDBREAKING treatment based on research by Spanish scientists has helped children born with incurable deafness hear for ...
The Highlands Current on MSN
5 Questions: Liz Wood
Liz Wood, who lives in Beacon, is the founder of The MYT1L Project ( myraregene.org ), a foundation that supports families whose children are affected by a rare genetic disorder.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback